IRIS
MORISCO, FILOMENA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 12.008
NA - Nord America 10.456
EU - Europa 7.035
SA - Sud America 1.635
AF - Africa 322
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 14
Totale 31.488
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.047
SG - Singapore 5.627
RU - Federazione Russa 3.487
CN - Cina 2.169
VN - Vietnam 2.116
BR - Brasile 1.322
HK - Hong Kong 946
IT - Italia 895
FR - Francia 459
DE - Germania 417
UA - Ucraina 350
FI - Finlandia 321
NL - Olanda 279
CA - Canada 218
GB - Regno Unito 218
IN - India 197
JP - Giappone 182
SE - Svezia 170
BD - Bangladesh 150
IE - Irlanda 143
AR - Argentina 131
KR - Corea 102
MX - Messico 101
ZA - Sudafrica 82
IQ - Iraq 76
CI - Costa d'Avorio 75
ES - Italia 63
PL - Polonia 57
AT - Austria 54
PH - Filippine 52
ID - Indonesia 47
TH - Thailandia 47
TR - Turchia 46
EC - Ecuador 41
PK - Pakistan 37
VE - Venezuela 35
CO - Colombia 33
MA - Marocco 30
CL - Cile 29
TW - Taiwan 27
EG - Egitto 26
LT - Lituania 25
PY - Paraguay 25
JO - Giordania 23
AE - Emirati Arabi Uniti 18
KE - Kenya 18
UZ - Uzbekistan 18
JM - Giamaica 15
NG - Nigeria 15
SA - Arabia Saudita 15
NP - Nepal 14
AU - Australia 13
DZ - Algeria 13
HN - Honduras 13
TN - Tunisia 13
AZ - Azerbaigian 11
CR - Costa Rica 11
DO - Repubblica Dominicana 11
PS - Palestinian Territory 11
BE - Belgio 10
ET - Etiopia 10
KG - Kirghizistan 9
RO - Romania 9
AL - Albania 8
CZ - Repubblica Ceca 8
IL - Israele 8
MY - Malesia 8
NI - Nicaragua 8
PE - Perù 8
EU - Europa 7
KZ - Kazakistan 7
PT - Portogallo 7
GR - Grecia 6
LB - Libano 6
LV - Lettonia 6
XK - ???statistics.table.value.countryCode.XK??? 6
CH - Svizzera 5
GT - Guatemala 5
HU - Ungheria 5
OM - Oman 5
AM - Armenia 4
BA - Bosnia-Erzegovina 4
BB - Barbados 4
BS - Bahamas 4
BW - Botswana 4
CY - Cipro 4
PA - Panama 4
PR - Porto Rico 4
SY - Repubblica araba siriana 4
UY - Uruguay 4
BG - Bulgaria 3
BH - Bahrain 3
BN - Brunei Darussalam 3
BO - Bolivia 3
DK - Danimarca 3
GA - Gabon 3
GH - Ghana 3
HR - Croazia 3
IR - Iran 3
KH - Cambogia 3
Totale 31.407
Salva come PNG Salva come JPEG
Città #
Singapore 2.613
San Jose 1.477
Hong Kong 921
Moscow 855
Ashburn 772
Chandler 658
Ho Chi Minh City 588
Beijing 503
Santa Clara 477
Hanoi 453
Hefei 417
The Dalles 395
Lauterbourg 331
Los Angeles 313
Millbury 310
Jacksonville 285
Princeton 255
Amsterdam 230
Boston 225
New York 210
Buffalo 205
Nanjing 183
Tokyo 158
Naples 156
Des Moines 118
Council Bluffs 109
São Paulo 103
Redondo Beach 99
Munich 96
Napoli 94
Dallas 92
Da Nang 90
Haiphong 89
Dong Ket 88
Wilmington 81
Frankfurt am Main 79
Seoul 72
Ottawa 71
Nanchang 68
Chicago 63
Seattle 60
Orem 58
Mexico City 56
Lawrence 54
Toronto 54
Atlanta 48
Rio de Janeiro 48
Warsaw 48
Kochi 47
Brooklyn 43
Denver 42
Helsinki 42
London 42
Nuremberg 42
Shenyang 41
Hebei 40
Milan 40
Houston 37
Johannesburg 37
Turku 37
Montreal 36
Stockholm 35
Dublin 33
Poplar 32
Boardman 31
Norwalk 31
Tianjin 31
San Francisco 30
Düsseldorf 29
Rome 29
Washington 28
Jiaxing 27
Baghdad 26
Biên Hòa 26
Vienna 26
Chennai 25
Falkenstein 25
Hải Dương 25
Kronberg 25
Brasília 23
Thái Nguyên 23
Manchester 22
Phoenix 21
Porto Alegre 21
Can Tho 20
Amman 19
Changsha 19
Charlotte 19
Shanghai 19
Kunming 18
Bangkok 17
Ninh Bình 17
Salvador 17
Tashkent 17
Woodbridge 17
Belo Horizonte 16
Campinas 16
Curitiba 16
Dhaka 16
Mumbai 16
Totale 16.257
Salva come PNG Salva come JPEG
Nome #
Coffee reduces liver damage in a rat model of steatohepatitis: the underlying mechanisms and the role of polyphenols and melanoidins 449
The combination of berberine, tocotrienols and coffee extracts improves metabolic profile and liver steatosis by the modulation of gut microbiota and hepatic mir‐122 and mir‐34a expression in mice 434
Decaffeinated coffee reduces gut leakiness in rats fed with high-fat diet. The role of Occludin and Zonulin-1 233
Apple polyphenol extracts prevent damage to human gastric epithelial cells in vitro and to rat gastric mucosa in vivo 197
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 191
Metabolic-associated fatty liver disease (MAFLD) in coeliac disease 191
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 183
A holistic evaluation of patients with chronic Hepatitis D virus (HDV) infection enrolled in the Italian PITER-B and delta cohort 178
HCV clearance after direct-acting antivirals in patients with cirrhosis by stages of liver impairment: The ITAL-C network study 176
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial 172
Moderate coffee consumption increases plasma glutathione but not homocysteine in healthy subjects. 166
Anti-HDV reflex testing in HBsAg-positive subjects: An efficacious strategy to identify HDV infection 164
Clinical features and comorbidity pattern of HCV infected migrants compared to native patients in care in Italy: A real-life evaluation of the PITER cohort 159
Concomitant Interferon-alfa and chemotherapy in hepatitis C and colorectal cancer: a case report 156
Eradication of HCV in Renal Transplant Recipients and Its Effects on Quality of Life 155
Trends in chronic hepatitis B virus infection in Italy over a 10-year period: Clues from the nationwide PITER and MASTER cohorts toward elimination 152
Adherence to Barcelona Clinic Liver Cancer guidelines in field practice: Results of Progetto Epatocarcinoma Campania 152
A Simple Noninvasive Score Based on Routine Parameters can Predict Liver Cirrhosis in Patients With Chronic Hepatitis C 151
Viral Outcome in Patients with Occult HBV Infection or HCV-Ab Positivity Treated for Lymphoma 150
Coffee prevents fatty liver disease induced by a high-fat diet by modulating pathways of the gut-liver axis 145
Beneficial Effects of Silybin Treatment After Viral Eradication in Patients With HCV-Related Advanced Chronic Liver Disease: A Pilot Study 143
Material deprivation affects the management and clinical outcome of hepatocellular carcinoma in a high-resource environment 141
CIRANAD (Centro Interuniversitario per Ricerche su Alimenti Nutrizione ed Apparato Digerente) 141
Pattern of macrovascular invasion in hepatocellular carcinoma 141
Characteristics and survival of patients with primary biliary cholangitis and hepatocellular carcinoma 139
Liver stiffness assessment by transient elastography suggests high prevalence of liver involvement in common variable immunodeficiency 139
Use of Telemedicine for chronic liver disease at a single care center during the COVID-19 pandemic: Prospective observational study 139
Surveillance for hepatocellular carcinoma with a 3-months interval in “extremely high-risk” patients does not further improve survival 138
Overview of prognostic systems for hepatocellular carcinoma and ITA.LI.CA external validation of MESH and CNLC classifications 138
Alfa-glutathione transferases in HCV-related chronic hepatitis: a new predictive index of response to inteferon therapy? 138
Potential feasibility of atezolizumab-bevacizumab therapy in patients with hepatocellular carcinoma treated with tyrosine-kinase inhibitors 135
Direct-acting antivirals and hepatocellular carcinoma in chronic hepatitis C: A few lights and many shadows 135
L'avvento degli inibitori delle proteasi nella terapia dell'infezione da epatite C: Reazioni avverse dermatologiche 135
Decaffeinated coffee consumption induces expression of tight junction proteins in high fat diet fed rats 135
Laser ablation is superior to TACE in large-sized hepatocellular carcinoma: A pilot case-control study 134
On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites 134
Enhanced liver fibrosis score as a noninvasive biomarker in hepatitis C virus patients after direct-acting antiviral agents 133
Advanced liver disease outcomes after hepatitis C eradication by human immunodeficiency virus infection in PITER cohort 133
Prevalence and risk factors of HCV infection in a metropolitan area in southern Italy: Tail of a cohort infected in past decades 132
Incidence of DAA failure and the clinical impact of retreatment in real-life patients treated in the advanced stage of liver disease: Interim evaluations from the PITER network 132
Berberis aristata, elaeis guineensis and coffea canephora extracts modulate the insulin receptor expression and improve hepatic steatosis in NAFLD patients: A pilot clinical trial 132
A prospective study of direct-acting antiviral effectiveness and relapse risk in HCV cryoglobulinemic vasculitis by the Italian PITER cohort 130
Effectiveness of Hepatitis B Vaccination Campaign in Italy: Towards the Control of HBV Infection for the First Time in a European Country 129
Reduction of the Risk of Hepatocellular Carcinoma over Time Using Direct-Acting Antivirals: A Propensity Score Analysis of a Real-Life Cohort (PITER HCV) 129
Dietary supplementation of vitamin D prevents the development of western diet-induced metabolic, hepatic and cardiovascular abnormalities in rats 129
Predicting de-novo portal vein thrombosis after HCV eradication: A long-term competing risk analysis in the ongoing PITER cohort 128
Safety and efficacy of ombitasvir/paritaprevir/ritonavir/dasabuvir plus ribavirin in patients over 65 years with HCV genotype 1 cirrhosis 128
Hepatitis-C virus infection in Italy: a multicentric sero-epidemiological study. (A report from the HCV study group of the Italian Association for the Study of the Liver) 128
Coffee and Intestinal Permeability in a Mice Model of Non-Alcoholic Fatty Liver Disease 128
Circulating SCCA–IgM complex is a useful biomarker to predict the outcome of therapy in hepatocellular carcinoma patients 127
Metabolic disorders across hepatocellular carcinoma in Italy 127
Risk stratification of HCC occurrence after HCV eradication: a complicate plot of risk factors related and unrelated to the previous viral disease 127
Non-invasive assessment of portal hypertension in patients with primary biliary cholangitis is affected by severity of cholestasis 126
Lack of evidence that adherence to standard of care therapy improves survival in subjects with hepatocellular carcinoma in clinical practice 126
Profiling the risk of hepatocellular carcinoma after long-term HCV eradication in patients with liver cirrhosis in the PITER cohort 125
Recurrence of hepatocellular carcinoma after direct acting antiviral treatment for hepatitis C virus infection: Literature review and risk analysis 125
Decaffeinated Coffee Reduces Body Weight Gain in Rats Fed With a Hfd by Modulating Intestinal Gpr41 and CCK Expression 125
Prevalence of and risk factors for HBV infection in a metropolitan Southern Italian area: Evidence for the effectiveness of universal Hepatitis B vaccination 124
Development of a risk score to predict portal vein tumor thrombosis in patients with hepatocellular carcinoma 122
Coffee and liver health 122
Osteoporosis across chronic liver disease 122
Vitamin D levels and chronic hepatitis C 121
Plasma phospholipid dysregulation in patients with cystathionine-β synthase deficiency 121
Liver Resection vs Nonsurgical Treatments for Patients With Early Multinodular Hepatocellular Carcinoma 120
Reactivation of hepatitis B or C in patients with IBD receiving immunosuppressive drugs. A multicentre study 120
Long-term safety of anti-TNF-? in PsA patients with concomitant HCV infection: a retrospective observational multicenter study on 15 patients. 120
Current evidence in the field of the management with TNF-α inhibitors in psoriatic arthritis and concomitant hepatitis C virus infection 120
Effectiveness and safety of glecaprevir/pibrentasvir in chronic hepatitis C patients: Results of the Italian cohort of a post-marketing observational study 120
Decaffeinated Coffee Reduces Intestinal Leakiness in Rats Fed With a Hfd by Modulating Occludin and Zonulin-1 Expression 119
Timing strategies of direct-acting antivirals and biologics administration in HCV-infected subjects with inflammatory bowel diseases 119
Evaluation of the Effect Derived from Silybin with Vitamin D and Vitamin E Administration on Clinical, Metabolic, Endothelial Dysfunction, Oxidative Stress Parameters, and Serological Worsening Markers in Nonalcoholic Fatty Liver Disease Patients 119
Usefulness of a liver biopsy in the evaluation of patients with elevated ALT values and serological markers of hepatitis viral infection 118
BIOCHEMICAL MARKERS OF OXIDATIVE STRESS IN PERIPHERAL LYMPHOCYTES OF PATIENTS WITH HCV-RELATED LIVER DESEASES. 118
A nomogram-based prognostic model for advanced hepatocellular carcinoma patients treated with sorafenib: A multicenter study 118
Awareness of individual goals, preferences, and priorities of persons with severe congenital haemophilia A for a tailored shared decision-making approach to liver-directed gene therapy. A practical guideline 117
Sustained virological response by direct antiviral agents in HCV leads to an early and significant improvement of liver fibrosis 117
Visceral Obesity and Cytokeratin-18 Antigens as Early Biomarkers of Liver Damage 117
Humoral Response to 2-dose BNT162b2 mRNA COVID-19 Vaccination in Liver Transplant Recipients 116
Garlic extract prevents CCl(4)-induced liver fibrosis in rats: The role of tissue transglutaminase. 116
Asunaprevir, a protease inhibitor for the treatment of hepatitis C infection. 116
AISF position paper on liver transplantation and pregnancy: Women in Hepatology Group, Italian Association for the Study of the Liver (AISF) 116
Ultrasound-based transient elastography improves the detection of liver disease in common variable immunodeficiency 116
COVID-19 in liver transplant recipients: incidence, hospitalization and outcome in an Italian prospective double-centre study 116
PNPLA3, TM6SF2, and MBOAT7 Influence on Nutraceutical Therapy Response for Non-alcoholic Fatty Liver Disease: A Randomized Controlled Trial 115
Characteristics and outcome of anti-hepatitis D virus positive patients with hepatocellular carcinoma 115
Acute Delta Hepatitis in Italy spanning three decades (1991-2019): Evidence for the effectiveness of the hepatitis B vaccination campaign 115
Relevance of Bile Acids in Cholangiocarcinoma Pathogenesis: Critical Revision and Future Directions 115
Effect of immunosuppressive therapy on patients with inflammatory bowel diseases and hepatitis B or C virus infection. 115
Impact of Diabetes on Outcomes of Sorafenib Therapy for Hepatocellular Carcinoma 115
Modeling the time-related fluctuations of AFP and PIVKA-II serum levels in patients with cirrhosis undergoing surveillance for hepatocellular carcinoma 115
Association of Very Rare NOTCH2 Variants with Clinical Features of Alagille Syndrome 114
Vitamin D-PTH axis in HCV infection 114
Effect of Red Wine Polyphenols on the Expression of Transthyretin in Murine Choroid Plexus 114
Epidemiological trends and trajectories of MAFLD-associated hepatocellular carcinoma 2002-2033: the ITA.LI.CA database 113
Serum insulin-like growth factor I evaluation as a useful tool for predicting the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis: a prospective study. 113
ONLINE ANALYSIS OF BREATH BY PROTON TRANSFER REACTION TIME OF FLIGHT MASS SPECTROMETRY IN CIRRHOTIC PATIENTS 113
Coffee Restores Expression of lncRNAs Involved in Steatosis and Fibrosis in a Mouse Model of NAFLD 112
Spread of hepatitis C virus infection within families 112
AISF position paper on liver disease and pregnancy 112
The interpretation of liver function tests in pregnancy 112
Totale 13.882
Salva come PNG Salva come JPEG
Categoria #
all - tutte 103.572
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 103.572
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.337 24 6 14 2 1 21 15 52 125 61 281 735
2022/20231.631 320 90 17 115 230 181 12 133 221 223 75 14
2023/20241.297 36 245 194 78 40 119 9 134 18 26 269 129
2024/20258.341 458 620 19 72 207 391 810 500 914 859 2.776 715
2025/202616.000 1.761 1.278 1.585 1.349 2.667 688 1.605 1.058 1.940 974 352 743
2026/2027696 696 0 0 0 0 0 0 0 0 0 0 0
Totale 31.873